NeoTX is a specialty biopharmaceutical company, with a focus on research and development in oncology immunotherapy.
With a strong research and development team, our strategy is to build a patented, proprietary and unique product pipeline to capitalize on technologies that NeoTX is developing independently and through collaborative partnerships and license agreements.